Drug – bio-affecting and body treating compositions – Topical sun or radiation screening – or tanning preparations
Patent
1996-02-08
1999-03-23
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Topical sun or radiation screening, or tanning preparations
514675, 514863, A61K 742
Patent
active
058855572
ABSTRACT:
This invention relates to compositions useful in the phototherapeutic treatment of psoriasis and other proliferative skin diseases. The compositions of the present invention comprise dihydroxyacetone and a penetration attenuator, both in a cosmetically and/or pharmaceutically acceptable carrier. Optionally, the compositions of the present invention may also contain an acidic component. The compositions of the present invention are useful in the exploitation during phototherapeutic treatment of the hyper-desquamation characteristics of the psoriatic or otherwise affected skin.
REFERENCES:
patent: 2949403 (1960-08-01), Andreadis et al.
patent: 4325965 (1982-04-01), Chiba
patent: 4454159 (1984-06-01), Musher
patent: 4651739 (1987-03-01), Oseroff et al.
patent: 4708865 (1987-11-01), Turner
patent: 4981681 (1991-01-01), Tosti
patent: 5112613 (1992-05-01), Honda et al.
patent: 5122536 (1992-06-01), Perricone
patent: 5126135 (1992-06-01), Yamada et al.
patent: 5556612 (1996-09-01), Anderson et al.
Hruza, "Maximally Aggressive Phototherapy of Psoriasis Using Selectively Desquamating Topical Photoprotectants", 4th annual Photomedicine Conference, St. Louis, Missouri, Feb. 3, 1995.
Levy, "dihydroxyacetone-Containing Sunless or Self-Tanning Lotions", J. Am. Acad. Dermatol. 27:989-93 (1992).
Lui et al., "Photodynamic Therapy in Dermatology", arch Dermatol. 128:1631-1636 (1992).
McCullough et al., "Low Dose Photofrin Photodynamic Therapy of Psoriasis", Clin. Res. 39:509A (1991).
Carabott and Hawk, "A Modified Dosage Schedule For Increased Efficiency In PUVA Treatment of Psoriasis", Clin. and Exp. Derm. 14:337-340, (1989).
Follett et al., "Protection of Photosensitized Rats Against Long Ultraviolet Radiation by Topical Application of Compunds With Structures Similar to That of Dihydroxyacetone", Dermatologica, 175:58-63 (1987).
Honigsmann et al., "Oral Photochemotherapy With Psoralens and UVA (PUVA): Principles and Practice", Dermatology In General Medicine 3rd Ed., McGraw Hill, New York (1987).
Takahashi et al., "Measurement of Turnover Time of Stratum Corneum Using Dansyl Chloride Fluorescence", J. Soc. Cosmet. Chem., 38:321-331 (1987).
Weinstein et al., "Cell Kinetic Basis for Pathophysiology of Psoriasis", J. Invest. Dermatol. 85(6):579-583 (1985).
Ryatt et al., "The Usefulnes of Reflectance Spectorphotometric Measurements During Psoralens and Ultrviolet A Therapy for Psoriasis", J. Am. Acad. Dermatol. 9:558-562 (1983).
Parrish et al., "Photochemotherapy of Skin Diseases", The Science of Photomedicine, Plenum Press, New York (1982).
Parrish and Jaenicke, "Action Spectrum For Phototherapy of Psoriasis", J. Invest. Dermatol., 76(5):359-362 (1981).
Wolff and Honigsmann, "Clinical Aspects of Photochemotherapy", Pharma. Ther. 12:381-418 (1981).
"Research Needs in 11 Major Areas In Dermatology", J. Invest. Derm., 73:402-413 (1979).
Stern et al., "Risk of Cutaneous Carcinoma in Patients Treated With Oral Methoxsalen Photochemotherapy for Psoriasis", J. Med. 300(15):809-813 (1979).
Maibach and Kligman, "Dihydroxyacetone: A Suntan-Simulating Agent", Arch. Dermatol., 74:505-507 (1960).
Fowlks, "The Chemistry of the Psoralens", J. Invest. Derm. vol. 32, pp. 249-254 (1959).
Fitzpatrick and Pathak, "Historical Aspects of Methoxsalen and Other Furocoumarins", J. Inves. Derm., pp. 229-231 (1958).
Fowlks, "The Mechanism of the Photodynamic Effect", J. Inves. Derm., pp. 233-247 (1958).
Pathak, and Fizpatrick, "Relationship of Molecular Configuration to the activity of Furocoumarins Which Increase the Cutaneous Responses Following Long Wave Ultraviolet Radiation", J. Inves. Dermatol., pp. 255-262 (1958).
Dees Jos,e G.
Estee Lauder Inc.
Williamson Michael A.
LandOfFree
Compositions useful in the phototherapeutic treatment of prolife does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions useful in the phototherapeutic treatment of prolife, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions useful in the phototherapeutic treatment of prolife will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2122492